From clinical trials to regulatory submissions, ArtLingua bridges the gap between groundbreaking research and global impact, transforming complex medical knowledge into clear, accurate communication that advances healthcare worldwide. From scientific manuscripts to patient-friendly lay summaries, we ensure every audience can grasp your breakthrough.
Rely on us for
Clinical research and documentation
Turn research into reality and share it with the world.
Complex study designs become crystal-clear protocols, and regulatory hurdles become mere stepping stones. Breakthrough findings turn into influential publications, and local research turns into global knowledge.
Lay summaries and patient communications
Scientific information made accessible.
Complex scientific data becomes clear, accessible summaries for patients, ethics committees, and public stakeholders. We translate plain-language protocol summaries, trial results, and safety information, bridging the gap between your research and the people who need to understand it.
Regulatory submissions and drug labeling
Navigate the approval maze with confidence.
Dense regulatory language becomes compelling submissions, technical requirements turn into competitive advantages, and as a result, your therapeutic breakthrough clears regulatory pathways in record time.
Medical translation is all about preserving the hope behind every breakthrough.
For formally validated patient-facing instruments, see our Linguistic Validation service.
Success story: The tiny dosing detail that could have set back an EU launch
A promising pediatric medication was just weeks from European launch when our medical translator, a former hospital pharmacist, spotted something troubling in the German package leaflet.
On paper, the dosing calculation looked perfect. But she noticed a subtle error: the measuring instructions could have led caregivers to underdose the smallest patients. Not dangerous, but potentially ineffective.
We raised a formal query, we clarified dosing instructions in line with the approved SmPC, and audited every language version in scope. In doing so, we caught two other similar issues and delivered a correction strategy that kept the launch timeline intact.
The product launched on schedule in several EU markets and is now used in pediatric care.
Sometimes the smallest details make the biggest difference.
For high-volume regulatory content or strategic localization guidance, read about our Managed AI Translation and Localization Consulting services.
Related Resources
Scaling Multilingual Medical Content: How Healthcare Content Platforms Build Responsible AI Workflows
You manage large volumes of medical content...
Health App Cultural Adaptation: Beyond AI Translation
What’s the difference between a health app that...
Why Clinical Trial Plain Language Summaries Get Rejected – And How to Get Them Right the First Time
How can the same plain language summary pass...
How Cultural Precision Protects Your Medical Content Launch
When “Correct” Becomes a Risk You’ve checked the...
Frequently Asked Questions
ferme tout
What makes your medical translators different?
We work with medical translators who combine linguistic expertise with life sciences education and clinical experience. They understand the terminology, but they've also lived the science.
How do you protect our confidential research data?
Whether we’re using AI-enhanced or traditional human-only workflows, all projects are protected by strict confidentiality agreements, role-based access controls, and secure file transfer protocols.
Can you keep pace with evolving regulatory landscapes?
Our regulatory specialists stay up to date with major guideline updates (EMA, FDA) to track key changes. We always recommend final sign-off from your internal regulatory team before submission.
How do you handle multi-site international studies?
We apply consistent quality frameworks and terminology standards across all your research translations, ensuring uniform meaning and compliance requirements at every study site, and in every language.